Could a Simple Vaccine Help Lower Alzheimer’s Risk? New Research Says Yes

A recent study has uncovered a hopeful connection between the shingles vaccine and a lower risk of developing Alzheimer’s disease.

Researchers looked at over 2 million older adults in the U.S. and found that those who received the recombinant shingles vaccine (brand name Shingrix) were up to 30% less likely to develop Alzheimer's in the following years.

That’s a big number—and big news.

While the vaccine wasn’t made for brain health, scientists think it may quiet certain harmful immune reactions that can lead to inflammation in the brain. This inflammation is believed to play a role in Alzheimer’s.

🧠 Why this matters for caregivers and families:

• There is currently no cure for Alzheimer’s, but prevention is key.
  
  
• Vaccines are one of the simplest, most widely available tools for protecting health as we age.
  
  
• This shingles vaccine may offer bonus protection for the brain—not just the skin.

✅ What You Can Do:

1. Ask about Shingrix
   If you or your loved one is over 50, talk to your doctor or pharmacist about the Shingrix vaccine. It’s typically given in two doses, a few months apart.
   
   
2. Know the difference
   This study focused on Shingrix, not the older Zostavax vaccine. Shingrix is newer, non-live, and recommended by the CDC.
   
   
3. Keep up with vaccines
   Other research suggests that staying current on flu, COVID-19, and pneumonia vaccines may also help reduce dementia risk. It’s not just about avoiding illness—it’s about supporting long-term brain health.
   
   
4. Share this info
   Talk to others caring for aging loved ones. These findings give us another simple way to act proactively.

✨ Small steps like this can make a big difference.
Protecting the brain may start with a visit to your doctor or pharmacy.

🧪 A Quick Note on the Science

It’s exciting to see studies like this offering hope—but it’s also important to remember how science works.

Most large studies like this one are observational, meaning they look for patterns in real-world data. That means there could be other factors at play. For example, it’s possible that people who get the Shingrix vaccine are also the ones who are already more health-conscious—they may eat well, visit the doctor regularly, stay socially active, and exercise. All of these are also known to help reduce the risk of Alzheimer’s disease.

So while this research adds a valuable piece to the puzzle, it’s best to think of the vaccine as one tool in a bigger brain-health toolkit.

Want to read more about the study? Check out this article from Stanford Medicine:
Shingles vaccination linked to lower dementia risk – Stanford Medicine